Andrew R. Robbins
2017
In 2017, Andrew R. Robbins earned a total compensation of $2.7M as Chief Operating Officer at Array BioPharma, a 135% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $218,671 |
|---|---|
| Option Awards | $1,588,246 |
| Salary | $435,036 |
| Stock Awards | $459,990 |
| Other | $38,215 |
| Total | $2,740,158 |
Robbins received $1.6M in option awards, accounting for 58% of the total pay in 2017.
Robbins also received $218.7K in non-equity incentive plan, $435K in salary, $460K in stock awards and $38.2K in other compensation.
Rankings
In 2017, Andrew R. Robbins' compensation ranked 4,014th out of 14,666 executives tracked by ExecPay. In other words, Robbins earned more than 72.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,014 out of 14,666 | 73rd |
Division Manufacturing | 1,410 out of 5,772 | 76th |
Major group Chemicals And Allied Products | 405 out of 2,075 | 81st |
Industry group Drugs | 313 out of 1,731 | 82nd |
Industry Pharmaceutical Preparations | 250 out of 1,333 | 81st |
Source: SEC filing on September 13, 2017.
Robbins' colleagues
We found five more compensation records of executives who worked with Andrew R. Robbins at Array BioPharma in 2017.